Vcanbio Cell & Gene Engineering Corp., Ltd.

  • Market Cap: Large Cap
  • Industry: Miscellaneous
  • ISIN: CNE000000545
CNY
24.85
-0.13 (-0.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,442.11
1,565.73
1,580.99
1,546.82
1,527.27
1,314.33
1,372.26
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,442.11
1,565.73
1,580.99
1,546.82
1,527.27
1,314.33
1,372.26
Raw Material Cost
530.42
582.07
580.16
588.18
555.00
515.03
510.36
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.80
5.03
4.11
2.34
1.92
1.85
12.17
Selling and Distribution Expenses
597.14
650.22
673.01
671.12
714.12
588.85
585.31
Other Expenses
13.41
16.29
16.88
13.39
12.31
10.29
8.91
Total Expenditure (Excl Depreciation)
1,264.49
1,400.21
1,426.08
1,395.55
1,394.09
1,208.61
1,196.94
Operating Profit (PBDIT) excl Other Income
177.60000000000002
165.5
154.9
151.3
133.2
105.7
175.3
Other Income
35.68
29.70
44.90
26.19
40.38
99.46
26.34
Operating Profit (PBDIT)
340.81
346.87
343.17
321.94
306.90
288.30
300.32
Interest
2.80
5.03
4.11
2.34
1.92
1.85
12.17
Exceptional Items
5.60
-34.01
-33.49
-0.75
51.83
-265.77
-45.08
Gross Profit (PBDT)
911.69
983.66
1,000.84
958.64
972.26
799.30
861.89
Depreciation
152.55
157.58
161.14
153.87
140.43
96.39
101.20
Profit Before Tax
191.06
150.24
144.43
164.99
216.38
-75.71
141.87
Tax
70.92
46.59
34.03
48.53
71.75
37.83
59.52
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
113.83
100.35
106.45
112.99
155.32
-126.86
49.69
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
113.83
100.35
106.45
112.99
155.32
-126.86
49.69
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-10.30
-11.00
-7.90
-6.30
-4.11
-0.06
4.26
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
103.53
89.35
98.55
106.68
151.21
-126.92
53.95
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,706.57
3,595.09
3,684.06
3,555.80
3,463.45
3,396.35
3,353.70
Earnings per share (EPS)
0.25
0.22
0.23
0.24
0.33
-0.27
0.11
Diluted Earnings per share
0.25
0.22
0.23
0.24
0.33
-0.27
0.11
Operating Profit Margin (Excl OI)
10.58%
10.19%
8.67%
9.17%
8.26%
7.03%
12.59%
Gross Profit Margin
23.83%
19.66%
19.33%
20.61%
23.36%
1.57%
17.71%
PAT Margin
7.89%
6.41%
6.73%
7.3%
10.17%
-9.65%
3.62%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is -7.89% vs -0.97% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 15.77% vs -9.33% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -3.81% vs 6.34% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -44.00% vs 21.95% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Vcanbio Cell & Gene Engineering Corp., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,442.11
0
1,442.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,442.11
0
1,442.11
Raw Material Cost
530.42
0
530.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.80
0
2.80
Selling and Distribution Expenses
597.14
0
597.14
Other Expenses
13.41
0.00
13.41
Total Expenditure (Excl Depreciation)
1,264.49
0
1,264.49
Operating Profit (PBDIT) excl Other Income
177.62
0.00
177.62
Other Income
35.68
0
35.68
Operating Profit (PBDIT)
340.81
0
340.81
Interest
2.80
0
2.80
Exceptional Items
5.60
0
5.60
Gross Profit (PBDT)
911.69
0
911.69
Depreciation
152.55
0
152.55
Profit Before Tax
191.06
0
191.06
Tax
70.92
0
70.92
Provisions and contingencies
0
0
0.00
Profit After Tax
113.83
0
113.83
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
113.83
0
113.83
Share in Profit of Associates
0
0
0.00
Minority Interest
-10.30
0
-10.30
Other related items
0.00
0.00
0.00
Consolidated Net Profit
103.53
0
103.53
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,706.57
0
3,706.57
Earnings per share (EPS)
0.25
0
0.25
Diluted Earnings per share
0.25
0
0.25
Operating Profit Margin (Excl OI)
10.58%
0%
0.00
10.58%
Gross Profit Margin
23.83%
0%
0.00
23.83%
PAT Margin
7.89%
0%
0.00
7.89%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 144.21 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -7.89% vs -0.97% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 10.35 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 15.77% vs -9.33% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 30.51 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.81% vs 6.34% in Dec 2024

Annual - Interest
Interest 0.28 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -44.00% vs 21.95% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.58%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024